The prevalence of sight-threatening uveitis in Scotland

Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period betw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of ophthalmology 2007-01, Vol.91 (1), p.33-36
Hauptverfasser: Williams, G J, Brannan, S, Forrester, J V, Gavin, M P, Paterson-Brown, S P, Purdie, A T, Virdi, M, Olson, J A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 36
container_issue 1
container_start_page 33
container_title British journal of ophthalmology
container_volume 91
creator Williams, G J
Brannan, S
Forrester, J V
Gavin, M P
Paterson-Brown, S P
Purdie, A T
Virdi, M
Olson, J A
description Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. Results: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7–97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. Discussion: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the “missing population” exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition.
doi_str_mv 10.1136/bjo.2006.101386
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1857573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4012419821</sourcerecordid><originalsourceid>FETCH-LOGICAL-b588t-de5738b9662b3441ef79aecfcd36ff6730311747bf1720ecc84429bf7da692303</originalsourceid><addsrcrecordid>eNqFkcFv0zAUxi0EYt3gzA1FQnCYlM4vdmznggQVA6RRDgyuluM8ty5pUuykGv_9XKXa2C6cLOv9_L3v80fIK6BzACYu6k0_LygVc6DAlHhCZsCFygsqq6dkRimVOYCAE3Ia4yZdCwHyOTkBUYFQUsyIvF5jtgu4Ny12FrPeZdGv1kM-rAOaATvfrbJxj37wMfNd9sP2Q2u65gV55kwb8eXxPCM_Lz9dL77kV98_f118uMrrUqkhb7CUTNWVEEXNOAd0sjJonW2YcE5IRhmA5LJ2IAuK1irOi6p2sjGiKtL0jLyfdHdjvcXGYjcE0-pd8FsT_ureeP1w0vm1XvV7DaqUaXcSeHcUCP2fEeOgtz5abFMI7MeohWKKcSYT-OYRuOnH0KVwGqRUVcGlKhN1MVE29DEGdHdWgOpDJTpVog-V6KmS9OL1vwnu-WMHCXh7BEy0pnXBdNbHey7ZUyU_rM4nzscBb-7mJvzW6SNlqZe_Flpdflsulh-Z5ok_n_h6u_mvy1siZ6_k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1778924785</pqid></control><display><type>article</type><title>The prevalence of sight-threatening uveitis in Scotland</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Williams, G J ; Brannan, S ; Forrester, J V ; Gavin, M P ; Paterson-Brown, S P ; Purdie, A T ; Virdi, M ; Olson, J A</creator><creatorcontrib>Williams, G J ; Brannan, S ; Forrester, J V ; Gavin, M P ; Paterson-Brown, S P ; Purdie, A T ; Virdi, M ; Olson, J A ; on behalf of the Scottish Uveitis Network</creatorcontrib><description>Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. Results: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7–97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. Discussion: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the “missing population” exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition.</description><identifier>ISSN: 0007-1161</identifier><identifier>EISSN: 1468-2079</identifier><identifier>DOI: 10.1136/bjo.2006.101386</identifier><identifier>PMID: 16916876</identifier><identifier>CODEN: BJOPAL</identifier><language>eng</language><publisher>BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd</publisher><subject>Adolescent ; Adult ; Age ; Age Distribution ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Blindness - etiology ; Child ; Clinical Science - Scientific Report ; Data collection ; Female ; Humans ; Immunosuppression Therapy ; Male ; Medical personnel ; Medical sciences ; Middle Aged ; Miscellaneous ; National Health Service ; NHS ; Ophthalmology ; Population ; Prevalence ; Prospective Studies ; Scotland - epidemiology ; Sex Distribution ; Uvea diseases ; Uveitis - complications ; Uveitis - epidemiology ; Uveitis - immunology ; Visual impairment ; Workloads</subject><ispartof>British journal of ophthalmology, 2007-01, Vol.91 (1), p.33-36</ispartof><rights>Copyright 2007 British Journal of Ophthalmology</rights><rights>2007 INIST-CNRS</rights><rights>Copyright: 2007 Copyright 2007 British Journal of Ophthalmology</rights><rights>Copyright © 2007 BMJ Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b588t-de5738b9662b3441ef79aecfcd36ff6730311747bf1720ecc84429bf7da692303</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bjo.bmj.com/content/91/1/33.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bjo.bmj.com/content/91/1/33.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,230,314,723,776,780,881,3183,23550,27901,27902,53766,53768,77343,77374</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18348545$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16916876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, G J</creatorcontrib><creatorcontrib>Brannan, S</creatorcontrib><creatorcontrib>Forrester, J V</creatorcontrib><creatorcontrib>Gavin, M P</creatorcontrib><creatorcontrib>Paterson-Brown, S P</creatorcontrib><creatorcontrib>Purdie, A T</creatorcontrib><creatorcontrib>Virdi, M</creatorcontrib><creatorcontrib>Olson, J A</creatorcontrib><creatorcontrib>on behalf of the Scottish Uveitis Network</creatorcontrib><title>The prevalence of sight-threatening uveitis in Scotland</title><title>British journal of ophthalmology</title><addtitle>Br J Ophthalmol</addtitle><description>Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. Results: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7–97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. Discussion: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the “missing population” exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Blindness - etiology</subject><subject>Child</subject><subject>Clinical Science - Scientific Report</subject><subject>Data collection</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppression Therapy</subject><subject>Male</subject><subject>Medical personnel</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>National Health Service</subject><subject>NHS</subject><subject>Ophthalmology</subject><subject>Population</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Scotland - epidemiology</subject><subject>Sex Distribution</subject><subject>Uvea diseases</subject><subject>Uveitis - complications</subject><subject>Uveitis - epidemiology</subject><subject>Uveitis - immunology</subject><subject>Visual impairment</subject><subject>Workloads</subject><issn>0007-1161</issn><issn>1468-2079</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkcFv0zAUxi0EYt3gzA1FQnCYlM4vdmznggQVA6RRDgyuluM8ty5pUuykGv_9XKXa2C6cLOv9_L3v80fIK6BzACYu6k0_LygVc6DAlHhCZsCFygsqq6dkRimVOYCAE3Ia4yZdCwHyOTkBUYFQUsyIvF5jtgu4Ny12FrPeZdGv1kM-rAOaATvfrbJxj37wMfNd9sP2Q2u65gV55kwb8eXxPCM_Lz9dL77kV98_f118uMrrUqkhb7CUTNWVEEXNOAd0sjJonW2YcE5IRhmA5LJ2IAuK1irOi6p2sjGiKtL0jLyfdHdjvcXGYjcE0-pd8FsT_ureeP1w0vm1XvV7DaqUaXcSeHcUCP2fEeOgtz5abFMI7MeohWKKcSYT-OYRuOnH0KVwGqRUVcGlKhN1MVE29DEGdHdWgOpDJTpVog-V6KmS9OL1vwnu-WMHCXh7BEy0pnXBdNbHey7ZUyU_rM4nzscBb-7mJvzW6SNlqZe_Flpdflsulh-Z5ok_n_h6u_mvy1siZ6_k</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Williams, G J</creator><creator>Brannan, S</creator><creator>Forrester, J V</creator><creator>Gavin, M P</creator><creator>Paterson-Brown, S P</creator><creator>Purdie, A T</creator><creator>Virdi, M</creator><creator>Olson, J A</creator><general>BMJ Publishing Group Ltd</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20070101</creationdate><title>The prevalence of sight-threatening uveitis in Scotland</title><author>Williams, G J ; Brannan, S ; Forrester, J V ; Gavin, M P ; Paterson-Brown, S P ; Purdie, A T ; Virdi, M ; Olson, J A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b588t-de5738b9662b3441ef79aecfcd36ff6730311747bf1720ecc84429bf7da692303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Blindness - etiology</topic><topic>Child</topic><topic>Clinical Science - Scientific Report</topic><topic>Data collection</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppression Therapy</topic><topic>Male</topic><topic>Medical personnel</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>National Health Service</topic><topic>NHS</topic><topic>Ophthalmology</topic><topic>Population</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Scotland - epidemiology</topic><topic>Sex Distribution</topic><topic>Uvea diseases</topic><topic>Uveitis - complications</topic><topic>Uveitis - epidemiology</topic><topic>Uveitis - immunology</topic><topic>Visual impairment</topic><topic>Workloads</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williams, G J</creatorcontrib><creatorcontrib>Brannan, S</creatorcontrib><creatorcontrib>Forrester, J V</creatorcontrib><creatorcontrib>Gavin, M P</creatorcontrib><creatorcontrib>Paterson-Brown, S P</creatorcontrib><creatorcontrib>Purdie, A T</creatorcontrib><creatorcontrib>Virdi, M</creatorcontrib><creatorcontrib>Olson, J A</creatorcontrib><creatorcontrib>on behalf of the Scottish Uveitis Network</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, G J</au><au>Brannan, S</au><au>Forrester, J V</au><au>Gavin, M P</au><au>Paterson-Brown, S P</au><au>Purdie, A T</au><au>Virdi, M</au><au>Olson, J A</au><aucorp>on behalf of the Scottish Uveitis Network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prevalence of sight-threatening uveitis in Scotland</atitle><jtitle>British journal of ophthalmology</jtitle><addtitle>Br J Ophthalmol</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>91</volume><issue>1</issue><spage>33</spage><epage>36</epage><pages>33-36</pages><issn>0007-1161</issn><eissn>1468-2079</eissn><coden>BJOPAL</coden><abstract>Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. Results: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7–97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. Discussion: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the “missing population” exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition.</abstract><cop>BMA House, Tavistock Square, London, WC1H 9JR</cop><pub>BMJ Publishing Group Ltd</pub><pmid>16916876</pmid><doi>10.1136/bjo.2006.101386</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1161
ispartof British journal of ophthalmology, 2007-01, Vol.91 (1), p.33-36
issn 0007-1161
1468-2079
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1857573
source MEDLINE; BMJ Journals - NESLi2; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adolescent
Adult
Age
Age Distribution
Aged
Aged, 80 and over
Biological and medical sciences
Blindness - etiology
Child
Clinical Science - Scientific Report
Data collection
Female
Humans
Immunosuppression Therapy
Male
Medical personnel
Medical sciences
Middle Aged
Miscellaneous
National Health Service
NHS
Ophthalmology
Population
Prevalence
Prospective Studies
Scotland - epidemiology
Sex Distribution
Uvea diseases
Uveitis - complications
Uveitis - epidemiology
Uveitis - immunology
Visual impairment
Workloads
title The prevalence of sight-threatening uveitis in Scotland
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T07%3A38%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prevalence%20of%20sight-threatening%20uveitis%20in%20Scotland&rft.jtitle=British%20journal%20of%20ophthalmology&rft.au=Williams,%20G%20J&rft.aucorp=on%20behalf%20of%20the%20Scottish%20Uveitis%20Network&rft.date=2007-01-01&rft.volume=91&rft.issue=1&rft.spage=33&rft.epage=36&rft.pages=33-36&rft.issn=0007-1161&rft.eissn=1468-2079&rft.coden=BJOPAL&rft_id=info:doi/10.1136/bjo.2006.101386&rft_dat=%3Cproquest_pubme%3E4012419821%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1778924785&rft_id=info:pmid/16916876&rfr_iscdi=true